Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 05:42:20 2026-08-10 EDT			5-day change	1st Jan Change
2,597.95 ^INR	+0.19%		-2.23%	+5.14%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.62B	-	-	-	-
ELI LILLY AND COMPANY	1,057B		A
JOHNSON & JOHNSON	625B	-	BBB	-	-
ABBVIE INC.	435B		AA	-
ROCHE HOLDING AG	363B		AA
NOVARTIS AG	296B		AAA
ASTRAZENECA PLC	249B		A
AMGEN INC.	222B		A
NOVO NORDISK A/S	209B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	132B		A
VERTEX PHARMACEUTICALS INCORPORATED	126B		AA
GSK PLC	106B		AA
SANOFI	104B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.54B		AA
BAYER AG	56.57B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.09B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.41B		AA
HALEON PLC	43.91B		AA
Average	226.39B		AA
Weighted average by Cap.			AA